Elevated serum aluminium and lead in renal haemodialysis patients
Scientific Medical Journal. 1997; 9 (3): 69-77
em En
| IMEMR
| ID: emr-116397
Biblioteca responsável:
EMRO
ABSTRACT
Serum aluminium [Al] and lead [Pb] have been measured in dialysis patients with advanced renal failure [characterised by hyperkalaemia, hyperphosphataemia and hypocalcaemia] and in healthy subjects with normal kidney function for comparison. In those under dialysis, pre and post-dialysis levels of Al and Pb were evaluated. The results revealed increased serum Al [P = 0.01] and Pb [P < 0.05] in dialysis patients compared with normal controls. Post-dialysis level of serum Al increased [P < 0.01] than Pre-dialysis concentration. While no significant difference was detected between the levels of serum Pb in dialysis patients which were within the accepted safe limit for Pb exposure [below 40 ug/dl] in all patients, no evidence of Al or Pb toxicity was demonestrated
Buscar no Google
Índice:
IMEMR
Assunto principal:
Insuficiência Renal
/
Falência Renal Crônica
/
Chumbo
Limite:
Humans
/
Male
Idioma:
En
Revista:
Sci. Med. J.
Ano de publicação:
1997